|Building Name||Artemis Coromandel Hospital|
|Property Description||Multi-speciality Hospital|
|Physical Address||Coromandel, Mauritius|
|Site Area||8,968 m2|
|Start date||Q2 2024|
|No. of Parking Bays||192|
|Anticipated Completion||Q2 2025|
In response to the urgent requirement for private cancer treatment in Mauritius, especially of a more specialized nature, GREA will develop the first all-inclusive, state-of-the-art private Oncology offering in Mauritius in conjunction with local operator, Polyclinique de L’Ouest Lte (PDL). PDL has signed an operations and management agreement with Artemis Medicare Services Ltd (Artemis), a well established and recognised company launched by the promoters of Apollo Tyres Group in India, to operate the Falcon Curepipe and Coromandel Hospitals.
Given the lack of fully-fledged cancer treatment services in Mauritius, Falcon Coromandel Hospital by Artemis is targeting a unique offering with a specialised state-of-the-art oncology unit. The hospital will be a five-storey building over a total area of 10,482 m2 with 123 beds. Under the partnership with Artemis, Mauritian patients will have access to medical support related to Oncology treatment of an international standard, which is currently not available on the island. Artemis currently owns a 400 bed multi-speciality state-of-the-art hospital in Delhi that holds a Joint Commission International (JCI) accreditation. The hospital was established and has been operating successfully since 2007.
Artemis Hospital is considered a pioneer of healthcare systems in India, led by top-of-the-line medical technology and equipment. It was also the first hospital in Delhi to get NABH accreditation within three years of its start up. Artemis will be the operator for both Falcon Curepipe Hospital and Falcon Coromandel Hospital.